» Articles » PMID: 35324953

Association Between Self-reported Periodontitis and High-risk Oral Human Papillomavirus Infection Among Indigenous South Australians: A Cross-sectional Study

Overview
Journal PLoS One
Date 2022 Mar 24
PMID 35324953
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: The incidence of oropharyngeal squamous cell carcinoma (OPSCC) is increasing globally, reflecting an increase in human papillomavirus (HPV)-related lesions. Indigenous populations are disproportionately affected by OPSCCs. Currently, testing for oral HPV is not recommended as a screening tool to permit early detection of OPSCCs due to the high population prevalence of HPV infection. Periodontitis may be a marker of oral HPV infection, but previous research evaluating this association has been inconclusive. Here we report a large population-based study examining the association between high-risk oral HPV infection and periodontitis among Indigenous South Australians.

Methods: We utilised a large convenience sample of Indigenous South Australians aged 18+ years recruited between February 2018 and February 2020. Of the original cohort (n = 1011), 748 (73.9%) participants participated in the 12 month follow-up. Detailed information on sociodemographic characteristics, health-related behaviours, and sexual history were collected at enrolment. Saliva samples were collected at 12 months and tested for the presence of oral HPV DNA using the optimized general primer (GP) + PCR system. The primary outcomes were the prevalence of any high-risk oral HPV DNA, and separately, HPV 16 and/or 18. Periodontitis was assessed at follow-up by using validated self-reported periodontitis screening questions. Logistic regression analyses were undertaken to assess the association between self-reported periodontitis and oral HPV infection with adjustment for potential sociodemographic and behavioural confounders, with estimates presented as odds ratios (OR) and 95% confidence interval (CI).

Results: Data on 673 participants (89.9% of the follow-up cohort) were available. Participants ranged in age from 18 to 80 (mean age 42.2, SD 14.7) and 31.5% were male. Overall, 115 (17.1%) participants had self-reported periodontitis, 40 (5.9%) had any high-risk oral HPV and 14 (2.1%) had HPV 16 and/or 18. Any high-risk HPV was detected among seven (17.5%) participants and HPV 16 and/or 18 was detected in three (21.4%) who self-reported periodontitis. In the regression analyses no significant association was found between self-reported periodontitis and high-risk oral HPV (adjusted OR: 1.10; 95% CI: 0.45-2.70) or HPV 16 and/or 18 (adjusted OR: 1.27; 95% CI: 0.32-5.03).

Conclusion: This study did not find any association between self-reported periodontitis and high-risk oral HPV among Indigenous South Australians. Further targeted studies with standardized clinical measures of periodontal disease are needed to clarify the link between high-risk oral HPV and periodontal disease. If confirmed this would add further weight to the importance of recommendations about the utility of periodontitis screening to identify individuals at risk of carrying high-risk oral HPV, who may benefit from more intensive screening and ongoing monitoring.

Citing Articles

Validity of the self-reported number of teeth in independent older people in Japan.

Shimazaki Y, Saito M, Nonoyama T, Inamoto Y BMC Geriatr. 2024; 24(1):900.

PMID: 39482622 PMC: 11526520. DOI: 10.1186/s12877-024-05512-1.


Prevalence of Human Papillomavirus (HPV)-16 in Different Dental Infections in the Lebanese Population.

Khalil W, Alaa El Din F, Jaffal M, Kanj A, Nabbouh A, Kurban M Cureus. 2023; 15(5):e38809.

PMID: 37303381 PMC: 10251111. DOI: 10.7759/cureus.38809.

References
1.
Kapellas K, Ali A, Jamieson L . Modelling the Validity of Periodontal Disease Screening Questions in a Nondental Clinical Setting. Int Dent J. 2021; 71(5):407-413. PMC: 9275349. DOI: 10.1016/j.identj.2020.12.013. View

2.
Kapellas K, Skilton M, Maple-Brown L, Do L, Bartold P, ODea K . Periodontal disease and dental caries among Indigenous Australians living in the Northern Territory, Australia. Aust Dent J. 2014; 59(1):93-9. DOI: 10.1111/adj.12135. View

3.
DSouza G, Kreimer A, Viscidi R, Pawlita M, Fakhry C, Koch W . Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med. 2007; 356(19):1944-56. DOI: 10.1056/NEJMoa065497. View

4.
Lechner M, Breeze C, OMahony J, Masterson L . Early detection of HPV-associated oropharyngeal cancer. Lancet. 2019; 393(10186):2123. DOI: 10.1016/S0140-6736(19)30227-2. View

5.
Castellsague X, Alemany L, Quer M, Halec G, Quiros B, Tous S . HPV Involvement in Head and Neck Cancers: Comprehensive Assessment of Biomarkers in 3680 Patients. J Natl Cancer Inst. 2016; 108(6):djv403. DOI: 10.1093/jnci/djv403. View